$CPER
United States Commodity Index Funds Trust

2020 Q1 Form 10-Q Financial Statement

#000110465920058625 Filed on May 08, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q4 2019 Q1
Revenue -$54.66M $18.76M
YoY Change -391.34%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $465.2K $1.321M
YoY Change -64.78%
Operating Profit
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$55.12M $17.46M
YoY Change -415.65%
Net Earnings / Revenue 93.08%
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 12.45M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q1 2019 Q4 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $110.3M $169.7M $419.3M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $129.0M $200.0M
YoY Change -57.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities $436.4K $3.103M
YoY Change 184.55%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity
YoY Change
Total Liabilities & Shareholders Equity $129.0M $200.0M
YoY Change -57.95%

Cashflow Statement

Concept 2020 Q1 2019 Q4 2019 Q1
OPERATING ACTIVITIES
Net Income -$55.12M $17.46M
YoY Change -415.65%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$45.68M $2.163M
YoY Change -2211.61%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -15.09M -36.91M
YoY Change -59.11%
NET CHANGE
Cash From Operating Activities -45.68M 2.163M
Cash From Investing Activities
Cash From Financing Activities -15.09M -36.91M
Net Change In Cash -60.77M -34.75M
YoY Change 74.88%
FREE CASH FLOW
Cash From Operating Activities -$45.68M $2.163M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q1 dei Amendment Flag
AmendmentFlag
false
CY2020Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001479247
CY2020Q1 dei Document Type
DocumentType
10-Q
CY2020Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2020Q1 dei Document Period End Date
DocumentPeriodEndDate
2020-03-31
CY2020Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2020Q1 dei Entity File Number
EntityFileNumber
001-34833
CY2020Q1 dei Entity Registrant Name
EntityRegistrantName
United States Commodity Index Funds Trust
CY2020Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2020Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-1537655
CY2020Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
1850 Mt. Diablo Boulevard, Suite 640
CY2020Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Walnut Creek
CY2020Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2020Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94596
CY2020Q1 dei City Area Code
CityAreaCode
510
CY2020Q1 dei Local Phone Number
LocalPhoneNumber
522-9600
CY2020Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2020Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2020Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q1 dei Entity Shell Company
EntityShellCompany
false
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
110328123
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
169737534
CY2020Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
26314145
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
27676364
CY2020Q1 usci Unrealized Gain Loss On Open Commodity Futures Contracts
UnrealizedGainLossOnOpenCommodityFuturesContracts
-7763469
CY2019Q4 usci Unrealized Gain Loss On Open Commodity Futures Contracts
UnrealizedGainLossOnOpenCommodityFuturesContracts
2485118
CY2020Q1 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
72033
CY2019Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
67629
CY2020Q1 us-gaap Dividends Receivable
DividendsReceivable
6220
CY2019Q4 us-gaap Dividends Receivable
DividendsReceivable
26873
CY2020Q1 us-gaap Interest Receivable
InterestReceivable
0
CY2019Q4 us-gaap Interest Receivable
InterestReceivable
125
CY2020Q1 us-gaap Prepaid Insurance
PrepaidInsurance
22567
CY2019Q4 us-gaap Prepaid Insurance
PrepaidInsurance
20451
CY2020Q1 us-gaap Accrued Fees And Other Revenue Receivable
AccruedFeesAndOtherRevenueReceivable
0
CY2019Q4 us-gaap Accrued Fees And Other Revenue Receivable
AccruedFeesAndOtherRevenueReceivable
350
CY2020Q1 us-gaap Assets
Assets
128979619
CY2019Q4 us-gaap Assets
Assets
200014444
CY2020Q1 us-gaap Due To Correspondent Brokers
DueToCorrespondentBrokers
0
CY2019Q4 us-gaap Due To Correspondent Brokers
DueToCorrespondentBrokers
429967
CY2020Q1 usci Payable For Shares Redeemed
PayableForSharesRedeemed
0
CY2019Q4 usci Payable For Shares Redeemed
PayableForSharesRedeemed
1843700
CY2020Q1 us-gaap Due To Officers Or Stockholders Current And Noncurrent
DueToOfficersOrStockholdersCurrentAndNoncurrent
95603
CY2019Q4 us-gaap Due To Officers Or Stockholders Current And Noncurrent
DueToOfficersOrStockholdersCurrentAndNoncurrent
147346
CY2020Q1 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
317810
CY2019Q4 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
636133
CY2020Q1 us-gaap Commissions Payable To Broker Dealers And Clearing Organizations
CommissionsPayableToBrokerDealersAndClearingOrganizations
14455
CY2019Q4 us-gaap Commissions Payable To Broker Dealers And Clearing Organizations
CommissionsPayableToBrokerDealersAndClearingOrganizations
33805
CY2020Q1 us-gaap Due To Other Related Parties Current And Noncurrent
DueToOtherRelatedPartiesCurrentAndNoncurrent
8579
CY2019Q4 us-gaap Due To Other Related Parties Current And Noncurrent
DueToOtherRelatedPartiesCurrentAndNoncurrent
11634
CY2020Q1 us-gaap Liabilities
Liabilities
436447
CY2019Q4 us-gaap Liabilities
Liabilities
3102585
CY2020Q1 usci Sponsor Capital Account
SponsorCapitalAccount
1000
CY2019Q4 usci Sponsor Capital Account
SponsorCapitalAccount
1000
CY2020Q1 usci Unitholder Capital Account
UnitholderCapitalAccount
128542172
CY2019Q4 usci Unitholder Capital Account
UnitholderCapitalAccount
196910859
CY2020Q1 usci Trust Capital Account
TrustCapitalAccount
128543172
CY2019Q4 usci Trust Capital Account
TrustCapitalAccount
196911859
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
128979619
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
200014444
CY2020Q1 us-gaap Capital Units Outstanding
CapitalUnitsOutstanding
5200000
CY2019Q4 us-gaap Capital Units Outstanding
CapitalUnitsOutstanding
5550000
CY2020Q1 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-45109589
CY2019Q1 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-3614118
CY2020Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-10248587
CY2019Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
19586203
CY2020Q1 us-gaap Trading Securities Realized Gain Loss
TradingSecuritiesRealizedGainLoss
17668
CY2019Q1 us-gaap Trading Securities Realized Gain Loss
TradingSecuritiesRealizedGainLoss
0
CY2020Q1 us-gaap Dividend Income Operating
DividendIncomeOperating
58027
CY2019Q1 us-gaap Dividend Income Operating
DividendIncomeOperating
121110
CY2020Q1 us-gaap Interest Income Operating
InterestIncomeOperating
617334
CY2019Q1 us-gaap Interest Income Operating
InterestIncomeOperating
2661699
CY2020Q1 us-gaap Other Income
OtherIncome
5950
CY2019Q1 us-gaap Other Income
OtherIncome
6650
CY2020Q1 us-gaap Revenues
Revenues
-54659197
CY2019Q1 us-gaap Revenues
Revenues
18761544
CY2020Q1 us-gaap Management Fee Expense
ManagementFeeExpense
335246
CY2019Q1 us-gaap Management Fee Expense
ManagementFeeExpense
931123
CY2020Q1 us-gaap Professional Fees
ProfessionalFees
47257
CY2019Q1 us-gaap Professional Fees
ProfessionalFees
188418
CY2020Q1 us-gaap Floor Brokerage Exchange And Clearance Fees
FloorBrokerageExchangeAndClearanceFees
55793
CY2019Q1 us-gaap Floor Brokerage Exchange And Clearance Fees
FloorBrokerageExchangeAndClearanceFees
178430
CY2020Q1 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
26908
CY2019Q1 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
22850
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
465204
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
1320821
CY2020Q1 usci Expense Waiver
ExpenseWaiver
4405
CY2019Q1 usci Expense Waiver
ExpenseWaiver
21918
CY2020Q1 usci Net Operating Expenses
NetOperatingExpenses
460799
CY2019Q1 usci Net Operating Expenses
NetOperatingExpenses
1298903
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-55119996
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
17462641
CY2019Q4 usci Trust Capital Account
TrustCapitalAccount
196911859
CY2020Q1 usci Capital Contributions
CapitalContributions
8658579
CY2020Q1 usci Capital Account Redemptions
CapitalAccountRedemptions
21907270
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-55119996
CY2020Q1 usci Trust Capital Account
TrustCapitalAccount
128543172
CY2019Q4 usci Trust Capital Account Units
TrustCapitalAccountUnits
5550000
CY2020Q1 usci Capital Account Units Contributed
CapitalAccountUnitsContributed
350000
CY2020Q1 usci Capital Account Units Redeemed
CapitalAccountUnitsRedeemed
700000
CY2020Q1 usci Trust Capital Account Units
TrustCapitalAccountUnits
5200000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-55119996
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
17462641
CY2020Q1 usci Increase Decrease In Shortterm Investments
IncreaseDecreaseInShorttermInvestments
0
CY2019Q1 usci Increase Decrease In Shortterm Investments
IncreaseDecreaseInShorttermInvestments
-295216
CY2020Q1 us-gaap Unrealized Gain Loss On Derivatives And Commodity Contracts
UnrealizedGainLossOnDerivativesAndCommodityContracts
-10248587
CY2019Q1 us-gaap Unrealized Gain Loss On Derivatives And Commodity Contracts
UnrealizedGainLossOnDerivativesAndCommodityContracts
19586203
CY2020Q1 us-gaap Increase Decrease Due From Officers And Stockholders
IncreaseDecreaseDueFromOfficersAndStockholders
4404
CY2019Q1 us-gaap Increase Decrease Due From Officers And Stockholders
IncreaseDecreaseDueFromOfficersAndStockholders
21919
CY2020Q1 us-gaap Increase Decrease In Dividends Receivable
IncreaseDecreaseInDividendsReceivable
-20653
CY2019Q1 us-gaap Increase Decrease In Dividends Receivable
IncreaseDecreaseInDividendsReceivable
42808
CY2020Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-125
CY2019Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-3894
CY2020Q1 us-gaap Increase Decrease In Prepaid Insurance
IncreaseDecreaseInPrepaidInsurance
2116
CY2019Q1 us-gaap Increase Decrease In Prepaid Insurance
IncreaseDecreaseInPrepaidInsurance
-8368
CY2020Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-350
CY2019Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
0
CY2020Q1 us-gaap Increase Decrease In Payables To Broker Dealers
IncreaseDecreaseInPayablesToBrokerDealers
-429967
CY2019Q1 us-gaap Increase Decrease In Payables To Broker Dealers
IncreaseDecreaseInPayablesToBrokerDealers
4333965
CY2020Q1 usci Increase Decrease Management Fees Payable
IncreaseDecreaseManagementFeesPayable
-51743
CY2019Q1 usci Increase Decrease Management Fees Payable
IncreaseDecreaseManagementFeesPayable
-64243
CY2020Q1 usci Increase Decrease In Professional Fees Payable
IncreaseDecreaseInProfessionalFeesPayable
-318323
CY2019Q1 usci Increase Decrease In Professional Fees Payable
IncreaseDecreaseInProfessionalFeesPayable
-224100
CY2020Q1 us-gaap Increase Decrease In Broker Dealer Related Receivables Payables Net
IncreaseDecreaseInBrokerDealerRelatedReceivablesPayablesNet
19350
CY2019Q1 us-gaap Increase Decrease In Broker Dealer Related Receivables Payables Net
IncreaseDecreaseInBrokerDealerRelatedReceivablesPayablesNet
0
CY2020Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-3055
CY2019Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-1566
CY2020Q1 us-gaap Increase Decrease In Insurance Liabilities
IncreaseDecreaseInInsuranceLiabilities
0
CY2019Q1 us-gaap Increase Decrease In Insurance Liabilities
IncreaseDecreaseInInsuranceLiabilities
1
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-45679239
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2163246
CY2020Q1 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
8658579
CY2019Q1 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
5451099
CY2020Q1 usci Payments To Redemption Of Units
PaymentsToRedemptionOfUnits
23750970
CY2019Q1 usci Payments To Redemption Of Units
PaymentsToRedemptionOfUnits
42365085
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-15092391
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-36913986
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-60770630
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-34750740
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
197413898
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
490625457
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
136642268
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
455874717
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
110328123
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
419322802
CY2020Q1 usci Cash And Cash Equivalents Equity In Trading Account
CashAndCashEquivalentsEquityInTradingAccount
26314145
CY2019Q1 usci Cash And Cash Equivalents Equity In Trading Account
CashAndCashEquivalentsEquityInTradingAccount
36551915
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
136642268
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
455874717
CY2020Q1 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
CY2020Q1 usci Deferred Issuance Costs Amortization Period
DeferredIssuanceCostsAmortizationPeriod
P12M
CY2020Q1 usci Cash Equivalents Maturity Period
CashEquivalentsMaturityPeriod
P6M
CY2020Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Times New Roman';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Reclassification</p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Certain amounts in the accompanying condensed financial statements were reclassified to conform to the current presentation.</p>
CY2020Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">The preparation of condensed financial statements in conformity with U.S. GAAP requires USCF to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements, and the reported amounts of the revenue and expenses during the reporting period. Actual results may differ from those estimates and assumptions.</p>
CY2009Q4 usci Capital Contributions Initial
CapitalContributionsInitial
1000
CY2009Q4 usci Common Units Issued For Acquisition
CommonUnitsIssuedForAcquisition
20
CY2010Q3 usci Fee Paid Per Order
FeePaidPerOrder
1000
CY2020Q1 usci Future Contract Rebalance Target Weightage
FutureContractRebalanceTargetWeightage
0.0714
CY2020Q1 us-gaap Trustee Fees
TrusteeFees
3000
CY2020Q1 us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
20000
CY2019Q1 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-3351005
CY2020Q1 us-gaap Unrealized Gain Loss On Derivatives And Commodity Contracts
UnrealizedGainLossOnDerivativesAndCommodityContracts
-8497099
CY2019Q1 us-gaap Unrealized Gain Loss On Derivatives And Commodity Contracts
UnrealizedGainLossOnDerivativesAndCommodityContracts
18150103

Files In Submission

Name View Source Status
0001104659-20-058625-index-headers.html Edgar Link pending
0001104659-20-058625-index.html Edgar Link pending
0001104659-20-058625.txt Edgar Link pending
0001104659-20-058625-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
usci-20200331.xsd Edgar Link pending
usci-20200331x10q.htm Edgar Link pending
usci-20200331x10q001.jpg Edgar Link pending
usci-20200331x10q002.jpg Edgar Link pending
usci-20200331x10q003.jpg Edgar Link pending
usci-20200331x10q004.jpg Edgar Link pending
usci-20200331x10q005.jpg Edgar Link pending
usci-20200331x10q006.jpg Edgar Link pending
usci-20200331x10q007.jpg Edgar Link pending
usci-20200331x10q008.jpg Edgar Link pending
usci-20200331x10q009.jpg Edgar Link pending
usci-20200331x10q010.jpg Edgar Link pending
usci-20200331x10q011.jpg Edgar Link pending
usci-20200331x10q012.jpg Edgar Link pending
usci-20200331x10q_htm.xml Edgar Link completed
usci-20200331xex31d1.htm Edgar Link pending
usci-20200331xex31d2.htm Edgar Link pending
usci-20200331xex32d1.htm Edgar Link pending
usci-20200331xex32d2.htm Edgar Link pending
usci-20200331_cal.xml Edgar Link unprocessable
usci-20200331_def.xml Edgar Link unprocessable
usci-20200331_lab.xml Edgar Link unprocessable
usci-20200331_pre.xml Edgar Link unprocessable